Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)

NCT00092560 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
587
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Organon and Co